Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- QNRX
- Price
- 8.70
- Stock movement up
- +0.22 (3.13%)
- Company name
- Quoin Pharmaceuticals Ltd DRC
- Exchange
- (NASDAQ ,
- Currency
- USD )
- Sector
- Healthcare >Biotechnology
- Market cap
- 4.28M
- Ent value
- 7.11M
- Price/Sales
- 27.67
- Price/Book
- 0.79
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- 1356.20%
- 3 year return
- -50.52%
- 5 year return
- -
- 10 year return
- -
Last updated: 2025-09-15
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
DIVIDENDS
QNRX does not pay dividends or no data was received
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | 27.67 |
| Price to Book | 0.79 |
| EV to Sales | 45.96 |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 588.17K |
| EPS (TTM) | -1.75 |
| FCF per share (TTM) | -1.78 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 154.77K |
| Gross profit (TTM) | 78.64K |
| Operating income (TTM) | -9.21M |
| Net income (TTM) | -8.74M |
| EPS (TTM) | -1.75 |
| EPS (1y forward) | -5.55 |
Margins
Loading...
Margins data
| Gross margin (TTM) | 50.81% |
| Operating margin (TTM) | -5948.33% |
| Profit margin (TTM) | -5648.18% |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 3.12M |
| Net receivables | 0.00 |
| Total current assets | 10.50M |
| Goodwill | 0.00 |
| Intangible assets | 508.33K |
| Property, plant and equipment | 0.00 |
| Total assets | 11.39M |
| Accounts payable | 222.64K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 3.47M |
| Total liabilities | 5.95M |
| Shareholder's equity | 5.44M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -8.88M |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -8.88M |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | -160.65% |
| Return on Assets | -76.76% |
| Return on Invested Capital | -160.65% |
| Cash Return on Invested Capital | -163.22% |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 7.08 |
| Daily high | 7.28 |
| Daily low | 7.08 |
| Daily Volume | 2K |
| All-time high | 1980.00 |
| 1y analyst estimate | 40.67 |
| Beta | 1.82 |
| EPS (TTM) | -1.75 |
| Dividend per share | - |
| Ex-div date | - |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| QNRX | S&P500 | |
| Current price drop from All-time high | -99.63% | -1.46% |
| Highest price drop | -99.99% | -56.47% |
| Date of highest drop | 8 Apr 2025 | 9 Mar 2009 |
| Avg drop from high | -96.41% | -10.99% |
| Avg time to new high | 480 days | 12 days |
| Max time to new high | 959 days | 1805 days |
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
COMPANY DETAILS
Marketcap
4.28M
Marketcap category
Small-cap
Description
Quoin Pharmaceuticals, Ltd., a late stage specialty pharmaceutical company, focuses on the development and commercialization of therapeutic products for rare and orphan diseases in the United States. The company's lead product is QRX003, a topical lotion to treat Netherton Syndrome (NS). It also developing QRX004 for the treatment of recessive dystrophic epidermolysis bullosa; QRX007 to treat Netherton Syndrome; and QRX008 for the treatment of scleroderma. It has a research agreement with Queensland University of Technology; a license agreement with Skinvisible Inc.; consulting agreements with Axella Research LLC; and a Master Service Agreement with Therapeutics Inc. Quoin Pharmaceuticals, Ltd. was founded in 2018 and is based in Ashburn, Virginia. Quoin Pharmaceuticals, Ltd. is a subsidiary of Skinvisible, Inc.
Employees
3
Website
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
iO Charts is a Seeking Alpha partner
iO Charts is a Seeking Alpha partner
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
Seeking AlphaPress releases
iO Charts is a Seeking Alpha partnerNext page